Rigel Pharmaceuticals
RIGL
#6826
Rank
ยฃ0.46 B
Marketcap
ยฃ25.48
Share price
-0.85%
Change (1 day)
48.03%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): ยฃ91.03 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.28 Billion. In 2024 the company made an earning of ยฃ19.21 Million, an increase over its 2023 earnings that were of -ยฃ13.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ91.03 M373.8%
2024 ยฃ19.21 M-244.27%
2023 -ยฃ13.32 Million-66.79%
2022 -ยฃ40.11 Million340.73%
2021 -ยฃ9.11 Million-56.15%
2020 -ยฃ20.76 Million-57.34%
2019 -ยฃ48.66 Million-7.66%
2018 -ยฃ52.69 Million-9.47%
2017 -ยฃ58.2 Million24.46%
2016 -ยฃ46.77 Million23.63%
2015 -ยฃ37.83 Million-43.29%
2014 -ยฃ66.71 Million2.5%
2013 -ยฃ65.08 Million
2010 ยฃ27.67 M-133.97%
2009 -ยฃ81.47 Million-18.49%
2008 -ยฃ99.94 Million71.91%
2007 -ยฃ58.14 Million84.74%
2006 -ยฃ31.47 Million-10.17%
2005 -ยฃ35.04 Million-15.73%
2004 -ยฃ41.57 Million39.29%
2003 -ยฃ29.85 Million10.3%
2002 -ยฃ27.06 Million48.3%
2001 -ยฃ18.25 Million-2.13%
2000 -ยฃ18.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
ยฃ6.02 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.56 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-ยฃ79.7 Million-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI
-ยฃ95.47 Million-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA